| 1. |
- Granberg, Sarah, et al.
(författare)
-
The Development of ICF Core Sets for Hearing Loss
- 2010
-
Ingår i: Perspectives on Audiology. ; 6:1, s. 20-23
-
Tidskriftsartikel (refereegranskat)abstract
- The International Classification of Functioning, Disabilityand Health (ICF), adopted by the World Health Organization (WHO) in 2001, offers a framework for a comprehensive understandingof health. One of the main goals of the ICF is to provide aconceptual framework of health that can be applied both forresearch purposes and in clinical settings. In order to promotethe use of the ICF in clinical settings, the WHO initiated theCore Sets project. Core Sets, targeting a specific health condition,consist of a set of ICF categories that can serve as minimalstandards (Brief ICF Core Set) or as standards for comprehensiveassessment (Comprehensive ICF Core Set). In 2009, a processof developing ICF Core Sets for Hearing Loss was initiated.This process involves three phases of development. In the firstphase, four scientific studies are conducted to collect evidencefor relevant ICF categories to be used in the Core Sets. Inphase two, a consensus conference is held to establish relevantICF categories, and in the third phase, the Core Sets that areretained are tested and validated. This paper describes theprocess of developing ICF Core Sets for Hearing Loss as wellas an invitation to participate in the project
|
|
| 2. |
- Jansson-Fröjmark, Markus, et al.
(författare)
-
Cognitive-behavioral therapy for insomnia co-morbid with hearing impairment : a randomized controlled trial
- 2012
-
Ingår i: Journal of clinical psychology in medical settings. - 1068-9583. ; 19:2, s. 224-234
-
Tidskriftsartikel (refereegranskat)abstract
- The purpose of the current study was to examine the effects of cognitive behavior therapy (CBT-I) for insomnia on patients with insomnia co-morbid with hearing impairment. A randomized controlled design was used with a 3-month follow-up. Thirty-two patients with insomnia co-morbid with hearing impairment were randomized to either CBT-I or a waitlist condition (WLC). The primary outcome was insomnia severity. Secondary outcomes were sleep diary parameters, dysfunction, anxiety, and depression. Compared to WLC, CBT-I resulted in lower insomnia severity at post-treatment and at follow-up (d = 1.18–1.56). Relative to WLC, CBT-I also led, at both assessment points, to reduced total wake time (d = 1.39) and increased sleep restoration (d = 1.03–1.07) and sleep quality (d = 0.91–1.16). Both groups increased their total sleep time, but no significant group difference emerged. Compared to WLC, CBT-I resulted in higher function (d = 0.81–0.96) and lower anxiety (d = 1.29–1.30) at both assessment points. Neither CBT-I nor WLC led to improvement on depression. Based on the Insomnia Severity Index, more CBT-I (53–77%) than WLC participants (0–7%) were treatment responders. Also, more CBT-I (24%) than WLC participants (0%) remitted. In patients with insomnia co-morbid with hearing impairment, CBT-I was effective in decreasing insomnia severity, subjective sleep parameters, dysfunction, and anxiety. These findings are in line with previous results on the effects of CBT-I in other medical conditions.
|
|
